FDA Clears T2 Biosystems’ Key Update in Sepsis Battle
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
- Latest
- Trending
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
Investment firm Jefferies maintains its Buy rating on Vestis Corp, highlighting its well-executed turnaround strategy and potential for margin improvement ...
WiSA Technologies, Inc. has priced its public offering at approximately $10 million as part of its expansion plans in the ...
Deutsche Bank downgrades Masonite International's stock rating and increases price target, citing promising benefits from the recent agreement with Owens ...
UBS upgrades GE HealthCare Technologies to Neutral, raises price target to $88. Positive outlook for company's margin improvement and revenue ...
Bitcoin and Ethereum remain steady, with slight declines but still above key levels. Some cryptocurrencies gained traction while others faced ...
Shares of TOP Financial Group Ltd. tumbled 12.2% in premarket trading today after a surge on Friday. The stock's volatility ...
Jefferies upgrades Lincoln National to "Hold" rating, raising price target to $26.00. Upgrade based on expected RBC ratio and strategy ...
The Knesset Finance Committee has begun debating Israel's 2024 budget, facing opposition and economic concerns. Concerns over the budget's viability ...
JPMorgan gives an optimistic outlook for Palmer Square Capital BDC, assigning it an Overweight rating and $17.00 price target. The ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.